The Role of Platelet‐Activating Factor in Cerebral Ischemia and Related Disorders
The Role of Platelet‐Activating Factor in Cerebral Ischemia and Related Disorders
复制标题
血小板激活因子在脑缺血及相关疾病中的作用
DOI:
10.1111/j.1749-6632.1989.tb22617.x
复制
发表时间:
1989
影响因子:
5.2
通讯作者:
N. G. Bazan
中科院分区:
文献类型:
--
作者:
P. Braquet;B. Spinnewyn;C. Demerlé;D. Hosford;V. Marcheselli;M J Rossowska;N. G. Bazan
Platelet-activating factor (PAF) is a potent autacoid mediator implicated in a diverse range of human pathologies, including asthma, shock, cardiac and systemic anaphylaxis, ulceration, psoriasis, immune and renal disorders, and a variety of inflammatory conditions (reviewed i n References 1,2). There is also considerable evidence suggesting the involvement of PAF in central nervous system (CNS) functions and ischemic diseases (reviewed in Reference 1). Originally isolated from antigen-stimulated rabbit basophils and characterized structurally is 1-O-alkyl-2(R)-acetyl-glycero-3-phosphocholine, the alkyl phospholipid is now known to be produced by, and act on, a variety of cell types, including neutrophils, eosinophils, monocytes, macrophages, platelets, and endothelial cells (reviewed in References 1,2). The synthesis of P A F upon cell stimulation is generally accepted as involving a deacylation of the precursor molecule, 1 -alkyl-2-acyl-glycero3-phosphocholine (1-alkyl-2-acyl-GPC) by a phospholipase A2 (PLA2) and a subsequent acetylation of the 2-lyso-PAF to the active PAF molecule by a specific acetyltransferase (reviewed in References 1,3). Studies on the pathophysiological role of PAF have been facilitated by a variety of synthetic and natural compounds that can specifically antagonize the mediator. Synthetic antagonists (reviewed in Reference 4)-for example, CV-6209 (Takeda), SRI 63-44 1 (Sandoz), and Ro 19-3704 (Hoffman-LaRoche)-are derived mainly from the PAF framcwork; although the structurally unrelated R P 55270 (RhonePoulenc), WEB 2086, and WEB 2170 (Boehringer) are also potent inhibitors. The largest group of specific PAF antagonists derive from natural sources and comprise: (i) the ginkgolides (i.e., BN 52021 ; Institut Henri Beaufour), unique twenty-carbon cage molecules from the leaves of Ginkgo biloba (reviewed in Reference 5); (ii) lignans such as kadsurenone isolated from Piper futokadsurae and the related synthetic furanoid frameworks L-652,73 1 and L-659,989 (Merck); and (iii) some gliotoxin-related compounds (i.e., FR-900452; Fusijawa) produced by various fungi and bacteria. In this review we will consider the role of PAF and the effects of some of the above antagonists in ischemic conditions. At the onset of brain ischemia, the activation of phospholipases A and C leads to the accumulation of free fatty acids and diacylglycerols.6 Since free polyunsaturated fatty acids are the predominant components of the enlarged free fatty acid pool,' the
DOI:
10.1016/0006-291x(82)90928-7
发表时间:
1982
影响因子:
3.1
作者:
Lee,TC;Malone,B;Wasserman,SI;Fitzgerald,V;Snyder,F
通讯作者:
Snyder,F
DOI:
--
发表时间:
1987
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Bussolino,F;Camussi,G;Aglietta,M;Braquet,P;Bosia,A;Pescarmona,G;Sanavio,F;D'Urso,N;Marchisio,PC
通讯作者:
Marchisio,PC
影响因子:
8.3
作者:
SHAH, AB;BEAMER, N;COULL, BM
通讯作者:
COULL, BM